Iris Acquisition Corp II (IRAB) - Net Assets
Based on the latest financial reports, Iris Acquisition Corp II (IRAB) has net assets worth $162.98 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($170.41 Million) and total liabilities ($7.43 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Iris Acquisition Corp II tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $162.98 Million |
| % of Total Assets | 95.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Iris Acquisition Corp II - Net Assets Trend (2025–2025)
This chart illustrates how Iris Acquisition Corp II's net assets have evolved over time, based on quarterly financial data. Explore IRAB cash flow metrics to assess how effectively this company generates cash.
Annual Net Assets for Iris Acquisition Corp II (2025–2025)
The table below shows the annual net assets of Iris Acquisition Corp II from 2025 to 2025. For live valuation and market cap data, see Iris Acquisition Corp II market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-43.02K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Iris Acquisition Corp II's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $575.00 | % |
| Other Components | $24.43K | % |
| Total Equity | $-43.02K | 100.00% |
Iris Acquisition Corp II Competitors by Market Cap
The table below lists competitors of Iris Acquisition Corp II ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LIWANLI Innovation Co Ltd
TW:3054
|
$172.02 Million |
|
Forte Biosciences Inc
NASDAQ:FBRX
|
$172.07 Million |
|
Cartesian Therapeutics Inc.
NASDAQ:RNAC
|
$172.18 Million |
|
Shanghai Highly Group Co Ltd B
SHG:900910
|
$172.21 Million |
|
Bluerock Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLRK
|
$171.98 Million |
|
Garuda Construction & Engineering
NSE:GARUDA
|
$171.91 Million |
|
Sanurhasta Mitra PT
JK:MINA
|
$171.89 Million |
|
Galectin Therapeutics Inc
NASDAQ:GALT
|
$171.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Iris Acquisition Corp II's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Iris Acquisition Corp II's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2025-12-31 | $0.00 | $9.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Iris Acquisition Corp II utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Iris Acquisition Corp II's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $195,667,826
- Average return on equity (ROE) among peers: 8.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Iris Acquisition Corp II (IRAB) | $162.98 Million | N/A | 0.05x | $172.02 Million |
| Artius II Acquisition Inc. (AACB) | $-60.27K | 0.00% | 0.00x | $233.06 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $267.11 Million |
| Ares Acquisition Corporation II (AACT) | $952.33 Million | 0.00% | 0.06x | $587.05 Million |
| AA Mission Acquisition Corp. (AAM) | $301.50 Million | 78.14% | 9.62x | $388.34K |
| Altenergy Acquisition Corp (AEAE) | $-7.47 Million | 0.00% | 0.00x | $72.22 Million |
| Activate Energy Acquisition Corp. Class A Ordinary Share (AEAQ) | $223.53 Million | 0.00% | 0.04x | $236.21 Million |
| American Exceptionalism Acquisition Corp. A (AEXA) | $328.45 Million | 0.00% | 0.06x | $390.44 Million |
| Aimei Health Technology Co., Ltd Ordinary Share (AFJK) | $72.31 Million | 3.53% | 0.02x | $101.35 Million |
| Aifeex Nexus Acquisition Corporation (AIFE) | $86.16 Million | -0.10% | 0.01x | $91.13 Million |
| AI TRANSPORTATION ACQUISITION CORP Ordinary shares (AITR) | $-4.24K | 0.00% | 0.00x | $86.22 Million |
About Iris Acquisition Corp II
Iris Acquisition Corp II does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. Iris Acquisition Corp II was incorporated in 2025 and is based in Dubai, the United Arab Emirates.